Inhibition of Ultraviolet Light B-Induced Cutaneous Inflammation by A Specific Cyclooxygenase-2 Inhibitor
Ultraviolet B (UVB) radiation is responsible for the majority of cutaneous damage following both acute and long-term exposure, and is believed to be the most important etiologic agent in human skin cancer. UVB carcinogenesis initially induces an inflammatory response characterized by edema, dermal infiltration of leukocytes, as well as the production and release of prostaglandins, which may be critical to the observed damaging effects of UVB light on skin. Recently, a specific cyclooxygenase-2 (COX-2) inhibitor, Celecoxib, was developed, which inhibits COX-2-induced inflammation without inhibiting the cytoprotective function of cyclooxygenase-1 (COX-1). Studies have demonstrated that oral administration of Celecoxib decreased the incidence of skin and colon tumors. Recently, the process of inflammation has been linked to tumor formation. The present study examined the effects of a topical application of Celecoxib on the acute UVB-induced cutaneous inflammatory response. We show that topical Celecoxib treatment effectively reduced many parameters of UVB-mediated inflammation, including edema, dermal myeloperoxidase activity, neutrophil infiltration,and prostaglandin E2 (PGE2) levels. By inhibiting this inflammatory response, topical Celecoxib treatment could ultimately be effective in preventing tumor development and progression in the skin, which is known to result from long-term UV exposure.
KeywordsNeutrophil Infiltration Hairless Mouse Important Etiologic Agent Prevent Tumor Development Human Skin Cancer
Unable to display preview. Download preview PDF.
- 2.R.N. Mitchell and R.S. Cotran, Acute and choursonic inflammation, in:Basic Pathology 6 ’ h editionby V. Kumar, R.S. Cotran and S.L. Robbins, eds., W.B. Saunders Co., Philadelphia (1997).Google Scholar
- 4.J.L. Wallace, Prostaglandins, NSAIDs, and cytoprotection, Gastroenterol Clin North Am. 21:L631 (1992).Google Scholar
- 8.L.F. Mamet, Aspirin and the potential role of prostaglandins in colon cancer, Cancer Res. 52:5575 (1992).Google Scholar
- 14.M.L. Parrett, H.M. Abou-Issa, G. Alshafie, M.S. Ross, R.E. Harris and F.M. Robertson, Comparative ability of ibuprofen and N-(4-hydroxyphenyl)retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms, Anti-Cancer Res. 19:5079 (1999).Google Scholar